Genetic testing

ForeSENTIA Pan-Cancer is an advanced oncogenetic test that allows molecular profiling of the tumor. This makes it possible to apply targeted therapy tailored to the individual patient's needs.

ForeSENTIA Pan-Cancer is an advanced oncogenetic test that allows molecular profiling of the tumor. This makes it possible to apply targeted therapy tailored to the individual patient's needs.

NeoThetis is an innovative, non-invasive liquid biopsy test that helps patients
with cancer select the optimal treatment.

A genetic test to select the most optimal method of cancer treatment, known as a liquid biopsy.

Comprehensive panel to assess predisposition to cancers of multiple organs due to genetic causes. The panel includes 54 genes. The test requires a blood sample.